Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04433208 · ClinicalTrials.gov registry record · NA
Dietary Supplement With and Without a Probiotic
A NA study, sponsored by Prolacta Bioscience.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT04433208: Completed NA study, sponsored by Prolacta Bioscience.
NCT04433208 is a NA study that has completed, run by Prolacta Bioscience. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04433208, a NA study, has completed, sponsored by Prolacta Bioscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.
Primary Outcome
qPCR analysis uses primers for species and strain on DNA extracted from stool samples and is reported as genome copies per nanogram of DNA. The higher the value, the greater indication of engraftment of B.infantis signal over time indicating retention of introduced species.
Interventions
- DIETARY_SUPPLEMENT Probiotic
- DIETARY_SUPPLEMENT Complex oligosaccharide
- OTHER PPI
- OTHER H2 Blocker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-03-13 |
| Est. Completion | 2020-12-02 |
| Phase | NA |
What the finished NCT04433208 record still lists
NCT04433208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Probiotic is the first listed.
NCT04433208 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04433208 about?
NCT04433208 is a clinical study titled "Dietary Supplement With and Without a Probiotic". Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.
What is the current status of trial NCT04433208?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2020-03-13. Estimated completion is 2020-12-02.
What interventions are being tested in trial NCT04433208?
The interventions under investigation include: Probiotic (DIETARY_SUPPLEMENT), Complex oligosaccharide (DIETARY_SUPPLEMENT), PPI (OTHER), H2 Blocker (OTHER).
Who is sponsoring clinical trial NCT04433208?
This trial is sponsored by Prolacta Bioscience, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04433208's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI